<DOC>
	<DOCNO>NCT02040259</DOCNO>
	<brief_summary>The purpose Trevo® Retriever Registry collect real world performance data Trevo Retriever intend restore blood flow neurovasculature remove thrombus patient experience ischemic stroke .</brief_summary>
	<brief_title>Trevo® Retriever Registry Post Market Surveillance</brief_title>
	<detailed_description>Trevo Retriever Registry prospective , open-label , consecutive enrollment , multi-center , international registry may enroll maximum 2000 patient 100 site worldwide . Revascularization status assess end procedure use modify TICI ( Thrombolysis Cerebral Infarction ) score . Additional data collection include : 1 . Day 90 mRS assessment 2 . Day 90 cause mortality 3 . Neurological deterioration 24 hour post procedure , define four point increase NIHSS score baseline score 4 . Rates device procedure relate serious adverse event ( AEs )</detailed_description>
	<criteria>Subjects experience acute ischemic stroke eligible restoration blood flow use approve Trevo Retriever neurovasculature remove thrombus Trevo Retriever initial mechanical neurothrombectomy device use remove thrombus Signed Informed Consent obtain Subject willing comply protocol followup requirement Anticipated life expectancy least 3 month The subject participate another mechanical neurothrombectomy device trial clinical trial study procedure treatment might confound study end point .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2017</verification_date>
	<keyword>ischemic stroke</keyword>
	<keyword>mechanical thrombectomy device</keyword>
	<keyword>Retriever</keyword>
</DOC>